ZTS vs. MRK, PFE, BMY, RPRX, JAZZ, CORT, PRGO, SUPN, PCRX, and OMER
Should you be buying Zoetis stock or one of its competitors? The main competitors of Zoetis include Merck & Co., Inc. (MRK), Pfizer (PFE), Bristol-Myers Squibb (BMY), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Corcept Therapeutics (CORT), Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), and Omeros (OMER). These companies are all part of the "pharmaceuticals" industry.
Zoetis vs.
Zoetis (NYSE:ZTS) and Merck & Co., Inc. (NYSE:MRK) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.
Merck & Co., Inc. received 81 more outperform votes than Zoetis when rated by MarketBeat users. However, 77.96% of users gave Zoetis an outperform vote while only 67.03% of users gave Merck & Co., Inc. an outperform vote.
92.8% of Zoetis shares are held by institutional investors. Comparatively, 76.1% of Merck & Co., Inc. shares are held by institutional investors. 0.2% of Zoetis shares are held by insiders. Comparatively, 0.1% of Merck & Co., Inc. shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Zoetis has a net margin of 26.55% compared to Merck & Co., Inc.'s net margin of 19.23%. Zoetis' return on equity of 51.98% beat Merck & Co., Inc.'s return on equity.
Zoetis presently has a consensus price target of $211.89, suggesting a potential upside of 27.64%. Merck & Co., Inc. has a consensus price target of $123.67, suggesting a potential upside of 26.19%. Given Zoetis' stronger consensus rating and higher probable upside, equities analysts clearly believe Zoetis is more favorable than Merck & Co., Inc..
Zoetis has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Merck & Co., Inc. has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500.
Zoetis pays an annual dividend of $1.73 per share and has a dividend yield of 1.0%. Merck & Co., Inc. pays an annual dividend of $3.24 per share and has a dividend yield of 3.3%. Zoetis pays out 32.5% of its earnings in the form of a dividend. Merck & Co., Inc. pays out 67.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Zoetis has raised its dividend for 14 consecutive years and Merck & Co., Inc. has raised its dividend for 14 consecutive years.
In the previous week, Merck & Co., Inc. had 42 more articles in the media than Zoetis. MarketBeat recorded 88 mentions for Merck & Co., Inc. and 46 mentions for Zoetis. Merck & Co., Inc.'s average media sentiment score of 1.33 beat Zoetis' score of 1.08 indicating that Merck & Co., Inc. is being referred to more favorably in the news media.
Zoetis has higher earnings, but lower revenue than Merck & Co., Inc.. Merck & Co., Inc. is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.
Summary
Zoetis beats Merck & Co., Inc. on 14 of the 21 factors compared between the two stocks.
Get Zoetis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:ZTS) was last updated on 1/20/2025 by MarketBeat.com Staff
Free ZTS Stock Alerts